2101-87-3Relevant articles and documents
Transient resonance Raman and density functional theory investigation of 4-methoxyphenylnitrenium and 4-ethoxyphenylnitrenium ions
Chan, Pik Ying,Ong, Shing Yau,Zhu, Peizhi,Zhao, Cunyuan,Phillips, David Lee
, p. 8067 - 8074 (2003)
This paper presents a transient resonance Raman and density functional theory study of 4-methoxyphenylnitrenium and 4-ethoxyphenylnitrenium ions in a largely aqueous environment. The transient Raman bands observed in conjunction with the (U)BPW91/cc-PVDZ
Photochemistry of Aryl Pentazoles: Para -Methoxyphenylpentazole
Geiger,Haas
, p. 7338 - 7348 (2015)
The photolysis of para-methoxyphenyl pentazole (MeOPP) in methylcyanide (MeCN), investigated in the far UV (FUV) and near UV (NUV) is compared with the photolysis of para-methoxyphenyl azide (MeOPA). The main photoproduct of MeOPP is MeOPA, which, due to
Helicenoid-based bis-1,2,3-triazole tweezer: Synthesis and selective iodide sensing
Kamble, Siddharth B.,Gawade, Prashant M.,Badani, Purav M.,Karnik, Anil V.
, p. 602 - 611 (2020)
Novel helicenoid based 1,2,3-triazole tweezer 4 was synthesized using a multistep synthetic protocol with high yields from 2,7-Dihydroxynaphtlene 3 as a precursor. This helicenoid-based bis-1,2,3-triazole tweezer 4 selectively causes non-covalent interact
Nickel Boride Catalyzed Reductions of Nitro Compounds and Azides: Nanocellulose-Supported Catalysts in Tandem Reactions
Proietti, Giampiero,Prathap, Kaniraj Jeya,Ye, Xinchen,Olsson, Richard T.,Dinér, Peter
supporting information, p. 133 - 146 (2021/11/04)
Nickel boride catalyst prepared in situ from NiCl2 and sodium borohydride allowed, in the presence of an aqueous solution of TEMPO-oxidized nanocellulose (0.01 wt%), the reduction of a wide range of nitroarenes and aliphatic nitro compounds. Here we describe how the modified nanocellulose has a stabilizing effect on the catalyst that enables low loading of the nickel salt pre-catalyst. Ni-B prepared in situ from a methanolic solution was also used to develop a greener and facile reduction of organic azides, offering a substantially lowered catalyst loading with respect to reported methods in the literature. Both aromatic and aliphatic azides were reduced, and the protocol is compatible with a one-pot Boc-protection of the obtained amine yielding the corresponding carbamates. Finally, bacterial crystalline nanocellulose was chosen as a support for the Ni-B catalyst to allow an easy recovery step of the catalyst and its recyclability for new reduction cycles.
New inha inhibitors based on expanded triclosan and di-triclosan analogues to develop a new treatment for tuberculosis
Chetty, Sarentha,Armstrong, Tom,Sharma Kharkwal, Shalu,Drewe, William C.,De Matteis, Cristina I.,Evangelopoulos, Dimitrios,Bhakta, Sanjib,Thomas, Neil R.
, (2021/05/03)
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) has reinforced the need for the development of new anti-TB drugs. The first line drug isoniazid inhibits InhA. This is a prodrug requiring activation by the enzyme KatG. Mutations in KatG have largely contributed to clinical isoniazid resistance. We aimed to design new ‘direct’ InhA inhibitors that obviate the need for activation by KatG, circumventing pre-existing resistance. In silico molecular modelling was used as part of a rational structure-based drug-design approach involving inspection of protein crystal structures of InhA:inhibitor complexes, including the broad spectrum antibiotic triclosan (TCS). One crystal structure exhibited the unusual presence of two triclosan molecules within the Mycobacterium tuberculosis InhA binding site. This became the basis of a strategy for the synthesis of novel inhibitors. A series of new, flexible ligands were designed and synthesised, expanding on the triclosan structure. Low Minimum Inhibitory Concentrations (MICs) were obtained for benzylphenyl compounds (12, 43 and 44) and di-triclosan derivative (39), against Mycobacterium bovis BCG although these may also be inhibiting other enzymes. The ether linked di-triclosan derivative (38) displayed excellent in vitro isolated enzyme inhibition results comparable with triclosan, but at a higher MIC (125 μg mL?1 ). These compounds offer good opportunities as leads for further optimisation.
